AMBU A/S NAM. B DK -,50AMBU A/S NAM. B DK -,50AMBU A/S NAM. B DK -,50

AMBU A/S NAM. B DK -,50

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.05EUR
Revenue estimate
‪177.83 M‬EUR
Market capitalization
‪3.93 B‬EUR
‪22.47 M‬EUR
‪638.72 M‬EUR
‪182.23 M‬
Beta (1Y)
0.48

About AMBU A/S

CEO
Britt Meelby Jensen
Website
Headquarters
Ballerup
Employees (FY)
‪4.62 K‬
Founded
1937
FIGI
BBG00KW50F95
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange AMBU A/S NAM. B DK -,50 stocks are traded under the ticker 547A.
AMBU A/S NAM. B DK -,50 is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
547A earnings for the last quarter are 0.04 EUR per share, whereas the estimation was 0.04 EUR resulting in a 7.41% surprise. The estimated earnings for the next quarter are 0.04 EUR per share. See more details about AMBU A/S NAM. B DK -,50 earnings.
AMBU A/S NAM. B DK -,50 revenue for the last quarter amounts to ‪168.41 M‬ EUR despite the estimated figure of ‪168.37 M‬ EUR. In the next quarter revenue is expected to reach ‪168.13 M‬ EUR.
Yes, you can track AMBU A/S NAM. B DK -,50 financials in yearly and quarterly reports right on TradingView.
547A net income for the last quarter is ‪12.34 M‬ EUR, while the quarter before that showed ‪10.70 M‬ EUR of net income which accounts for 15.30% change. Track more AMBU A/S NAM. B DK -,50 financial stats to get the full picture.
Like other stocks, 547A shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMBU A/S NAM. B DK -,50 stock right from TradingView charts — choose your broker and connect to your account.
547A reached its all-time high on Sep 30, 2009 with the price of 56.000 EUR, and its all-time low was 0.030 EUR and was reached on Jan 12, 2009.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has ‪4.62 K‬ employees. See our rating of the largest employees — is AMBU A/S NAM. B DK -,50 on this list?
We've gathered analysts' opinions on AMBU A/S NAM. B DK -,50 future price: according to them, 547A price has a max estimate of 17.37 EUR and a min estimate of 6.95 EUR. Read a more detailed AMBU A/S NAM. B DK -,50 forecast: see what analysts think of AMBU A/S NAM. B DK -,50 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMBU A/S NAM. B DK -,50 EBITDA is ‪89.05 M‬ EUR, and current EBITDA margin is 13.24%. See more stats in AMBU A/S NAM. B DK -,50 financial statements.